APA (7th ed.) Citation

Cremer, S., Pilgram, L., Berkowitsch, A., Stecher, M., Rieg, S., Shumliakivska, M., . . . group, L. s. (2021). Angiotensin II receptor blocker intake associates with reduced markers of inflammatory activation and decreased mortality in patients with cardiovascular comorbidities and COVID-19 disease. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Cremer, Sebastian, et al. Angiotensin II Receptor Blocker Intake Associates with Reduced Markers of Inflammatory Activation and Decreased Mortality in Patients with Cardiovascular Comorbidities and COVID-19 Disease. Public Library of Science (PLoS), 2021.

MLA (8th ed.) Citation

Cremer, Sebastian, et al. Angiotensin II Receptor Blocker Intake Associates with Reduced Markers of Inflammatory Activation and Decreased Mortality in Patients with Cardiovascular Comorbidities and COVID-19 Disease. Public Library of Science (PLoS), 2021.